Evidence map›Paper›PMID 32218989›Full record

ArticleCell discovery2020

Identification of primordial germ cell-like cells as liver metastasis initiating cells in mouse tumour models.

Chunfang Liu, Zhan Ma, Zhen Cai, Fengyu Zhang, Cheng Liu, Tingjin Chen, Danni Peng, Xiaohong Xu, Hui-Kuan Lin

Open access · goldAbstract read
In one paragraph

Article in Cell discovery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. To Be or Not to Be a Germ Cell: The Extragonadal Germ Cell Tumor Paradigm.International journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Chunfang Liu *1Department of Laboratory Medicine, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, 200040 China.
Zhan Ma *1Department of Laboratory Medicine, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, 200040 China.
Zhen Cai2Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC 27157 USA.
Fengyu Zhang1Department of Laboratory Medicine, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, 200040 China.
Cheng Liu1Department of Laboratory Medicine, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, 200040 China.
Tingjin Chen2Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC 27157 USA.
Danni Peng2Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC 27157 USA.
Xiaohong Xu3Department of breast surgery, First Affiliated Zhejiang Provincial Hospital of Traditional Chinese Medicine, Hangzhou, 310006 China.
Hui-Kuan Lin2Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC 27157 USA.ORCID 0000-0002-3501-2410
Fudan University · CNWake Forest University · USZhejiang Provincial Hospital of TCM · CN

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Tumor Tissue CoreP30CA012197 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Ruben A. Mesa · 1985 to 2026
$55.4M
Identification of a new strategy for cancer therapyR01CA193813 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI LIN, HUI-KUAN · 2015 to 2019
$1.8M
Novel posttranslational modification in LKB1 activation and cancer developmentR01CA182424 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI LIN, HUI-KUAN · 2014 to 2018
$1.6M
NCI NIH HHS P30 CA012197NCI NIH HHS P30 CA016672NCI NIH HHS R01 CA182424NCI NIH HHS R01 CA193813
6 · The paper itself

Abstract

Liver metastasis, characterized by the spread of tumors to the liver from other areas, represents a deadly disease with poor prognosis. Currently, there is no effective therapeutic strategies and/or agents to combat liver metastasis primarily due to the insufficient understanding of liver metastasis. To develop a promising strategy for targeting liver metastasis, understanding of a cell origin responsible for liver metastasis and how this cell can be pharmacologically eliminated are therefore crucial. Using diverse tumor models including

Indexed as

CancerMechanisms of disease

Identifiers

PMID32218989
PMCPMC7090051
OpenAlexW3012813409

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.